-- A new guide has been launched for pet owners looking to improve their dog’s health and extend its lifespan by up to 14%. It shows how it’s possible to slow down diseases of old age like arthritis and liver disease while combating stress, anxiety and dementia.
More information can be found at: https://longevitylite.com/extendlifespanofdog
The new guide shows dog owners how they can gift their dog a longer, happier more comfortable life. It highlights how old age can be made more enjoyable, allowing dogs to live a fuller life for longer.
By using a natural drug called rapamycin, pet owners can increase the lifespan of their dogs and slow down the aging process.
Rapamycin was approved for human use by the FDA in 2007 to help with organ transplants. The Dog Aging Project began trials in 2014. The first phase focused on the safety of giving rapamycin to dogs. The results were ‘highly encouraging’ with no side effects and ‘strong justification’ for continuing the trials. The second phased focused on cardiac issues and delivered statistically significant improvements in heart function. The third phase, now underway, is expected to deliver up to 15% increase in dog lifespan over a 3 year period.
Studies show that rapamycin interventions delay or reverse molecular mechanisms of aging and have potential to greatly improve the health of dogs.
While the Dog Aging Project was small with only 23 dogs, a larger study is now being undertaken. Now dog owners across the country are starting to see the benefits. Anecdotal comments from dog owners taking part in the Dog Aging Project are noteworthy. 70% of owners reported their senior dog displayed increased activity and energy. 60% of owners reported their Senior dogs behaviour became more affectionate – clinicians think this might be down to arthritis pain reduction.
These outcomes also reflect the experience of “early adopter” senior dog owners who have independently started giving rapamycin to dogs in their normal home environment.
The data shows that there are some potential side effects, which include anaemia and fatigue – however, they are not much more dangerous than those of ordinary aspirin. In other words the benefits of taking rapamycin (like aspirin) greatly outweigh the risks of taking it.
All trials of rapamycin have used low level doses in order to achieve maximum benefits. The overwhelming evidence suggests that it’s a universal anti-aging drug that can extend the lifespan in all tested mammals.
Full details can be found on the URL above.
Release ID: 88952095